For the oxylipins lover and mass spec enthousiasm. one of the deprotomer oxylipin 9(S),12(S),13(S)-TriHODE from QCxMs in cid negative. Look at that nice deprotonation walk. Now we can believe what text book are telling us.
Check out this review from @KrishnaPKaliap1 & co @iitbombay in our latest issue covering the synthetic approaches and total syntheses of thapsigargin: a promising natural product with diverse medicinal potential
Read it in full below🔽
https://t.co/bcg615rU7V
Pleased that a collaborative research led by @Sleebs_Lab@WEHI_research has been published describing the design of a truncated dihydroquinazolinone scaffold with potent antimalarial activity that targets PfATP4.
https://t.co/7YwEiLEBmy
#AAHMSFellow @ausmedchemist, CEO & Managing Director Amplia Therapeutics, is an accomplished and highly regarded medicinal chemist and drug discoverer. He has worked in both industry and academia, and is an inventor on 29 patents and co-author of 68 scientific publications.
Co-supervised PhD available with me, Gideon Grogan and @EdAndersonGroup on biocatalytic oxygenation of bridged bicyclic hydrocarbons. Part of a new Oxford-York CDT (28 projects in total!). Inquiries and reposts welcome.
https://t.co/ujZobYAXBI
https://t.co/UCorjsWYHZ
$ATX | #Amplia is pleased to announce that it has that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to Amplia’s Focal Adhesion Kinase inhibitor, narmafotinib, for the treatment of advanced #pancreaticcancer.
https://t.co/RHbNHxYO3Y
Pleased that research led by @Sleebs_Lab@WEHI_research on optimization of a PfATP4 targeted antimalarial with curative and transmission blocking potential has been published.
https://t.co/fgCCQ4rk77
Super excited to be part of this EU consortium on macrocyclic drug discovery - info on 17 exciting PhD projects - including one in our lab @ChemistryatYork - coming soon!
The closing date for abstract submission for NZIC-24 is coming up! Make sure you submit yours before 15 July! We look forward to seeing you in Dunedin in November
Proud to announce publication of Comprehensive Chirality (2nd Edition)! Congratulations and heartfelt thanks to everyone who contributed to this monumental project. Check it out here: https://t.co/gyNy8SbkGf @elsevier@CNRSchimie@Univ_Paris_Cite#OrganicChemistry#ChemistryBooks
Ever wanted to visit the South Island of New Zealand?
Join us for NZIC-24 in Dunedin https://t.co/JXayXFoVqW
📢 November 24-28, 2024
Submit your Abstracts by 15 July 2024
Please RT #nzic24#nzchem